Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice

1. González-Sánchez, E.
2. Muñoz-Callejas, A.
3. Gómez-Román, J.
4. San Antonio, E.
5. Marengo, A.
6. Tsapis, N.
7. Bohne-Japiassu, K.
8. González-Tajuelo, R.
9. Pereda, S.
10. García-Pérez, J.
11. Cavagna, L.
12. González-Gay, M.Á.
13. Vicente-Rabaneda, E.F.
14. Meloni, F.
15. Fattal, E.
16. Castañeda, S.
17. Urzainqui, A.